New Submissions Are Not Currently Being Accepted
Samples sent after April 10, 2024 will be put on hold.
Viewing desktop version: Switch to Mobile
Sold as: Diclazepam
ID: 7338
Test Date: May 16, 2019
Pub. Date: May 16, 2019
Src Location: San Francisco, CA
Submitter Loc: San Francisco, CA
United States
Color: Off White / Yellow
Size: 349 mg, 8.10 mm x 22.90 mm
Data Source: DrugsData (EcstasyData)
Tested by: DDL
Lab's ID: 20190500014
Sold as: Diclazepam
Expected to be: Not Diclazepam
Lab comments:
AB-FUBINACA isomers not differentiated. Sample also contains many minor FUBINACA impurities. No Diclazepam detected.
Jun 5 2019 - The secondary chemical in this sample was originally identified by the lab as AB-FUBINACA. They have reanalyzed it and clarified that the compound is close to an isomer of AB-FUBINACA, and definitively not AB-FUBINACA.
Light yellow powder in capsule.